Power Law company profile

Immunome

Biotech & Life Sciences · Bothell, United States · Founded 2008 · IPO 2020 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1.95B

Market cap · Apr/2026

Revenue

$6.9M

Latest reported FY

Investors

9 investors on Immunome's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 3 investors entered at this stage

Series B+ 6 investors entered at this stage

Global footprint

Web traffic by country

8.6K monthly visits
across markets

🇺🇸 United States70.9%

🇬🇧 United Kingdom14%

🇨🇦 Canada12.8%

🇯🇵 Japan2.3%

Top 4 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo